Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Biopharma Inc (NASDAQ:TBPH)

12.54
Delayed Data
As of Jul 31
 +0.49 / +4.07%
Today’s Change
11.36
Today|||52-Week Range
30.38
-15.95%
Year-to-Date
No recent news for Theravance Biopharma Inc.

Today’s Trading

Previous close12.05
Today’s open12.04
Day’s range11.84 - 12.63
Volume85,506
Average volume (3 months)199,945
Market cap$423.9M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-52.24%
Earnings growth (this year)+22.79%
Earnings growth (next 5 years)+9.62%
Revenue growth (last year)+5,071.68%
P/E ratioNM
Price/Sales40.54
Price/Book1.39

Competitors

 Today’s
change
Today’s
% change
IDRAIdera Pharmaceutical...+0.13+3.77%
ANTHAnthera Pharmaceutic...+0.40+3.81%
INFIInfinity Pharmaceuti...+0.01+0.11%
RGLSRegulus Therapeutics...-0.06-0.73%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$1.51
Annual revenue (last year)$11.7M
Annual profit (last year)-$237.0M
Net profit margin-2,028.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
George Town, George Town

Forecasts